Amnion-derived pluripotent/multipotent stem cells.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 17237552)

Published in Stem Cell Rev on January 01, 2006

Authors

Toshio Miki1, Stephen C Strom

Author Affiliations

1: Department of Pathology, University of Pittsburgh, 200 Lothrop, St. Pittsburgh, PA 15213, USA.

Articles citing this

Liver regeneration. J Cell Physiol (2007) 6.69

Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med (2012) 1.92

Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem (2010) 1.41

Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol (2008) 1.10

Placental perivascular cells for human muscle regeneration. Stem Cells Dev (2010) 1.08

Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface (2010) 1.06

Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther (2011) 1.05

Clinical grade adult stem cell banking. Organogenesis (2009) 1.03

Placenta-derived stem cells: new hope for cell therapy? Cytotechnology (2008) 1.00

Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99

Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells. Mol Ther (2010) 0.94

Amnion formation in the mouse embryo: the single amniochorionic fold model. BMC Dev Biol (2011) 0.94

Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning (2014) 0.92

CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis (2012) 0.89

Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation. PLoS One (2013) 0.89

Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem Cells Dev (2012) 0.89

Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology (2013) 0.89

Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells (2012) 0.88

Pathological axes of wound repair: gastrulation revisited. Theor Biol Med Model (2010) 0.87

Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine. Aging (Albany NY) (2009) 0.87

Molecular characterization and in vitro differentiation of feline progenitor-like amniotic epithelial cells. Stem Cell Res Ther (2013) 0.86

Isolation and biological characterization of chicken amnion epithelial cells. Eur J Histochem (2012) 0.86

Amniotic mesenchymal stem cells: a new source for hepatocyte-like cells and induction of CFTR expression by coculture with cystic fibrosis airway epithelial cells. J Biomed Biotechnol (2012) 0.82

Characterization of amniotic stem cells. Cell Reprogram (2014) 0.81

The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med (2009) 0.81

Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80

Establishment and characterization of immortalized human amniotic epithelial cells. Cell Reprogram (2013) 0.79

Isolation and characterization of equine amnion mesenchymal stem cells. Cell Biol Int Rep (2010) (2011) 0.79

Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). Organogenesis (2013) 0.78

Effect of Culture Conditions on Reference Genes Expression in Placenta-derived Stem Cells. Int J Stem Cells (2009) 0.78

Isolation and Characterization of Human Mesenchymal Stem Cells Derived from Human Umbilical Cord Wharton's Jelly and Amniotic Membrane. Int J Organ Transplant Med (2013) 0.78

Culture, characterization and differentiation of cells from buffalo (Bubalus bubalis) amnion. Cytotechnology (2012) 0.76

Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche. Nat Mater (2016) 0.76

Differentiation of human amniotic epithelial cells into corneal epithelial-like cells in vitro. Int J Ophthalmol (2013) 0.75

Use of Amnion Transfer in Resistant Nonhealing Venous Leg Ulcers. Indian J Surg (2013) 0.75

From cellular to chemical approach for acute neural and alternative options for age-induced functional diseases. World J Stem Cells (2015) 0.75

Human Wharton's jelly-derived mesenchymal stem cells express oocyte developmental genes during co-culture with placental cells. Iran J Basic Med Sci (2015) 0.75

Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine. Int J Hematol Oncol Stem Cell Res (2017) 0.75

Progress in stem cell-derived technologies for hepatocellular carcinoma. Stem Cells Cloning (2010) 0.75

Evaluation of amniotic mesenchymal cell derivatives on cytokine production in equine alveolar macrophages: an in vitro approach to lung inflammation. Stem Cell Res Ther (2016) 0.75

Phenotype and multipotency of rabbit (Oryctolagus cuniculus) amniotic stem cells. Stem Cell Res Ther (2017) 0.75

Pathologic changes of wound tissue in rats with stage III pressure ulcers treated by transplantation of human amniotic epithelial cells. Int J Clin Exp Pathol (2015) 0.75

Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta. PLoS One (2017) 0.75

Mechanisms of human amniotic epithelial cell transplantation in treating stage III pressure ulcer in a rat model. Exp Ther Med (2015) 0.75

Articles by these authors

Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44

Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99

Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39

Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02

Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66

Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06

A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60

Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A (2010) 1.50

Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49

Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol (2007) 1.46

Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41

The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry (2010) 1.32

Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31

Frequent aneuploidy among normal human hepatocytes. Gastroenterology (2011) 1.30

Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol (2007) 1.29

Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos (2004) 1.19

Human hepatocyte transplantation. Methods Mol Biol (2010) 1.17

Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant (2011) 1.16

Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol (2005) 1.14

Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant (2005) 1.12

Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci (2003) 1.08

ChREBP mediates glucose-stimulated pancreatic β-cell proliferation. Diabetes (2012) 1.08

Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther (2007) 1.07

Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol (2007) 1.06

MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation. Mol Endocrinol (2011) 1.05

Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab Dispos (2002) 1.04

Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci (2010) 1.03

Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol (2010) 1.03

Side population cells derived from adult human liver generate hepatocyte-like cells in vitro. Dig Dis Sci (2005) 1.02

Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci (2006) 0.99

Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol (2005) 0.97

A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96

Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther (2009) 0.96

Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol (2008) 0.96

Production of hepatocyte-like cells from human amnion. Methods Mol Biol (2009) 0.95

Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci (2005) 0.94

Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta (2009) 0.94

Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. Drug Metab Dispos (2010) 0.93

The second extracellular loop dictates Occludin-mediated HCV entry. Virology (2010) 0.92

Isolation of amniotic mesenchymal stem cells. Curr Protoc Stem Cell Biol (2010) 0.92

New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res (2013) 0.92

A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development. Mol Pharmacol (2005) 0.92

Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. Drug Metab Dispos (2002) 0.91

In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging. Cell Transplant (2003) 0.89

Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Clin Cancer Res (2005) 0.89

Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology (2013) 0.89

Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab (2013) 0.88

Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. Chem Biol Interact (2008) 0.87

Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes. Drug Metab Dispos (2012) 0.85

Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s. Drug Metab Dispos (2013) 0.85

Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res (2015) 0.84

Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenet Genomics (2006) 0.84

Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases. Mol Endocrinol (2012) 0.84

Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos (2005) 0.84

FoxO1 links hepatic insulin action to endoplasmic reticulum stress. Endocrinology (2010) 0.84

To be or not to be: generation of hepatocytes from cells outside the liver. Gastroenterology (2008) 0.84

ATPase Class I Type 8B Member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes. Pediatr Res (2010) 0.83

Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. Clin Immunol (2010) 0.83

Mice with chimeric livers are an improved model for human lipoprotein metabolism. PLoS One (2013) 0.83

Naive rat amnion-derived cell transplantation improved left ventricular function and reduced myocardial scar of postinfarcted heart. Cell Transplant (2009) 0.83

Human pregnane X receptor activation and CYP3A4/CYP2B6 induction by 2,3-oxidosqualene:lanosterol cyclase inhibition. Drug Metab Dispos (2009) 0.82

Hypothermic storage of human hepatocytes for transplantation. Cell Transplant (2014) 0.81

Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites. Chem Res Toxicol (2007) 0.81

Rapid and sensitive assessment of human hepatocyte functions. Cell Transplant (2014) 0.81

Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer. Drug Metab Dispos (2013) 0.81

Regulation of CYP3A4 and CYP2B6 expression by liver X receptor agonists. Biochem Pharmacol (2007) 0.81

The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol (2014) 0.81

Induction of cyp3a in primary cultures of human hepatocytes by ginkgolides a and B. Clin Exp Pharmacol Physiol (2007) 0.80

Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis. Hepatology (2011) 0.80

Transactivation of a DR-1 PPRE by a human constitutive androstane receptor variant expressed from internal protein translation start sites. Nucleic Acids Res (2007) 0.80

Pharmacokinetics of tacrolimus and mycophenolic acid are altered, but recover at different times during hepatic regeneration in rats. Drug Metab Dispos (2004) 0.79

Potential barriers to human hepatocyte transplantation in MUP-uPAtg(⁺/⁺)Rag2⁻/⁻γC⁻/⁻ mice. Cell Transplant (2013) 0.79

Modulation of aflatoxin B1-mediated genotoxicity in primary cultures of human hepatocytes by diindolylmethane, curcumin, and xanthohumols. Toxicol Sci (2009) 0.79

A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS. J Pharm Biomed Anal (2012) 0.79

The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3). Mol Pharmacol (2012) 0.79

Bigger may not be better when it comes to hepatocytes. Liver Transpl (2006) 0.79

Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes. Drug Metab Dispos (2009) 0.78

Long term cultures of primary human hepatocytes as an alternative to drug testing in animals. ALTEX (2009) 0.78

Why do most human liver cytosol preparations lack xanthine oxidase activity? Drug Metab Dispos (2014) 0.77

Activity and expression of various isoforms of uridine diphosphate glucuronosyltransferase are differentially regulated during hepatic regeneration in rats. Pharm Res (2005) 0.77

Benzothiophene carboxylate derivatives as novel allosteric inhibitors of branched-chain α-ketoacid dehydrogenase kinase. J Biol Chem (2014) 0.77

Embryonic and induced pluripotent stem cells as a model for liver disease. Crit Rev Biomed Eng (2009) 0.77

Effects of green tea compounds on irinotecan metabolism. Drug Metab Dispos (2006) 0.76

Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions. Cell Transplant (2013) 0.76

Regulation of the human cathepsin E gene by the constitutive androstane receptor. Arch Biochem Biophys (2007) 0.76

Arsenic decreases RXRα-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes. Int Immunopharmacol (2012) 0.75